In the present study the effect of the indole alkaloid ibogaine on the in vitro lipolytic activity and adherence to epithelial cells of Candida albicans was investigated. The substance was administered intraperitoneally at a dose of 5 mg kg−1 day−1 in mice with disseminated and gastrointestinal C. albicans infections. Ibogaine significantly decreased the rate of mortality and the number of C. albicans c.f.u. recovered from the kidney, liver and spleen. Ibogaine interfered with the early stages of both disseminated and gastrointestinal C. albicans infections but did not reduce the number of C. albicans c.f.u. in the organs at the late phase of infections. The development of a specific immune response was not influenced by ibogaine, since the delayed-type hypersensitivity reaction to C. albicans and the production of interferon (IFN)-γ were similar in control and ibogaine-treated mice. The combined use of amphotericin B plus ibogaine in the treatment of mice with gastrointestinal infection reduced organ colonization more strongly than each substance alone.
AndrioleV. T.1999; The 1998 Garrod lecture.Current and future antifungal therapy: new targets for antifungal agents. J Antimicrob Chemother 44:151–162[CrossRef]
BaumannM. H.,
RothmanR. B.,
PabloJ. P.,
MashD. C.2001a; In vivo neurobiological effects of ibogaine and its O-desmethyl metabolite, 12-hydroxyibogamine (noribogaine), in rats. J Pharmacol Exp Ther 297:531–539
BennettD. E.,
McCrearyC. E.,
ColemanD. C.1998; Genetic characterization of a phospholipase C gene from Candida albicans : presence of homologous sequences in Candida species other than Candida albicans
. Microbiology 144:55–72[CrossRef]
CoxG. M.,
McDadeH. C.,
ChenS. C. & 8 other authors; 2001; Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans
. Mol Microbiol 39:166–175[CrossRef]
FidelP. L.Jr,
VazquezJ. A.,
SobelJ. D.1999; Candida glabrata : review of epidemiology, pathogenesis, and clinical disease with comparison to C.albicans
. Clin Microbiol Rev 12:80–96
FuY.,
IbrahimA. S.,
FonziW.,
ZhouX.,
RamosC. F.,
GhannoumM. A.1997; Cloning and characterization of a gene (LIP1) which encodes a lipase from the pathogenic yeast Candida albicans
. Microbiology 143:331–340[CrossRef]
GlickS. D.,
MaisonneuveI. M.,
SzumlinskiK. K.2000; 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. Ann N Y Acad Sci 914:369–386
GlickS. D.,
MaisonneuveI. M.,
SzumlinskiK. K.2001; Mechanisms of action of ibogaine: relevance to putative therapeutic effects and development of a safer iboga alkaloid congener. Alkaloids Chem Biol 56:39–53
HubeB.,
StehrF.,
BossenzM.,
MazurA.,
KretschmarM.,
SchaferW.2000; Secreted lipases of Candida albicans : cloning, characterisation and expression analysis of a new gene family with at least ten members. Arch Microbiol 174:362–374[CrossRef]
HubeB.,
HessD.,
BakerC. A.,
SchallerM.,
SchaferW.,
DolanJ. W.2001; The role and relevance of phospholipase D1 during growth and dimorphism of Candida albicans
. Microbiology 147:879–889
KaribaR. M.,
HoughtonP. J.,
YenesewA.2002; Antimicrobial activities of a new schizozygane indoline alkaloid from Schizozygia coffaeoides and the revised structure of isoschizogaline. J Nat Prod 65:566–569[CrossRef]
KomshianS. V.,
UwaydahA. K.,
SobelJ. D.,
CraneL. R.1989; Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 11:379–390[CrossRef]
LeidichS. D.,
IbrahimA. S.,
FuY. & 8 other authors; 1998; Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans
. J Biol Chem 273:26078–26086[CrossRef]
MashD. C.,
StaleyJ. K.,
PabloJ. P.,
HoloheanA. M.,
HackmanJ. C.,
DavidoffR. A.1995; Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex. Neurosci Lett 192:53–56[CrossRef]
MashD. C.,
KoveraC. A.,
PabloJ.,
TyndaleR. F.,
ErvinF. D.,
WilliamsI. C.,
SingletonE. G.,
MayorM.2000; Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures. Ann N Y Acad Sci 914:394–401
MukherjeeP. K.,
SeshanK. R.,
LeidichS. D.,
ChandraJ.,
ColeG. T.,
GhannoumM. A.2001; Reintroduction of the PLB1 gene into Candida albicans restores virulence in vivo
. Microbiology 147:2585–2597
SafferL. D.,
SchwartzmanJ. D.1991; A soluble phospholipase of Toxoplasma gondii associated with host cell penetration. J Protozool 38:454–460[CrossRef]
SugiyamaY.,
NakashimaS.,
MirbodF.,
KanohH.,
KitajimaY.,
GhannoumM. A.,
NozawaY.1999; Molecular cloning of a second phospholipase B gene, caPLB2 from Candida albicans
. Med Mycol 37:61–67
TsuboiR.,
KomatsuzakiH.,
OgawaH.1996; Induction of an extracellular esterase from Candida albicans and some of its properties. Infect Immun 64:2936–2940